Evidence map›Paper›PMID 41117501›Full record

ArticleJournal of the American Chemical Society2025

Retrosynthetic Design of Dinuclear Copper Enzymes for Azide-Alkyne Cycloaddition via Clickable Noncanonical Amino Acids.

Yunjong Lee, Jaewon Moon, Kyu Jin Son, Jaehee Lee, Seoungjun Ha, Woon Ju Song

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yunjong LeeDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
Jaewon MoonDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
Kyu Jin SonDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
Jaehee LeeDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
Seoungjun HaDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
Woon Ju SongDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0003-0434-2684

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper-catalyzed azide-alkyne cycloaddition (CuAAC) has enabled numerous synthetic and biological applications, driven by advances in the synthesis and optimization of copper-binding ligands. However, to the best of our knowledge, no bottom-up protein-based ligands have been specifically developed to catalyze this reaction. Here, we present a retrosynthetic protein design that leverages the introduction, duplication, and diversification of metal-chelating amino acid residues via a clickable noncanonical amino acid and CuAAC-mediated post-translational modification. A naturally occurring homodimer, dTDP-4-keto-6-deoxy-D-hexulose 3,5-epimerase, was engineered to structurally mimic the molecular framework of well-known CuAAC ligands, featuring multidentate triazole-containing motifs with four nitrogen donor atoms capable of accommodating two copper-binding sites. Remarkably, one protein construct R79TP exhibits CuAAC activity toward exogenous alkyne and azide substrates at rates exceeding that of a benchmark ligand, likely via a dinuclear mechanism. This work highlights the potential of genetically encoded precursors for multidentate ligand in proteins, expands the molecular complexity achievable in metalloenzyme engineering, and provides mechanistic insights and potential for copper-mediated bioorthogonal catalysis.

Indexed as

AlkynesAmino AcidsAzidesCopperClick ChemistryCycloaddition ReactionAlkynesAmino AcidsAzidesCopper

Identifiers

PMID41117501
PMCPMC12576778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.